Status
Conditions
Treatments
About
The biodegradable ABSORB scaffold is characterized by a greater strut thickness, but it has a greater flexibility compared to the XIENCE stent. Due to its fragility the inflating pressure of the ABSORB scaffold is limited and suitable lesions have to be well prepared. This study assesses the incidence of malapposed stent-struts, and the frequency of stent-underexpansion and edge dissection after ABSORB implantation compared to the XIENCE stent.
Enrollment
Sex
Volunteers
Inclusion and exclusion criteria
Inclusion Criteria for implanting an Absorb scaffold:
60 participants in 2 patient groups
Loading...
Central trial contact
Rudolf Berger, PD MD; Daniel Dalos, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal